Mutational Signatures Driven by Epigenetic Determinants Stratify Patients for Therapeutic Interventions in Gastric Cancer.

doi 10.1101/2020.04.17.20066944
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

A Mutational Signature in Gastric Cancer Suggests Therapeutic Strategies

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Mutational Signatures in Colon Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2019English

SigsPack, a Package for Cancer Mutational Signatures

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Epigenetic Determinants of Cancer

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2016English

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Improvement in Prediction of Prostate Cancer Prognosis With Somatic Mutational Signatures

Journal of Cancer
Oncology
2017English

The Pattern of Signatures in Gastric Cancer Prognosis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Epigenetic Modification of RhoE Expression in Gastric Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy